跳至主要内容
临床试验/NCT03397901
NCT03397901Unknown不适用

Transverse Colostomy for Refractory Hemorrhagic Chronic Radiation Proctitis With Moderate to Severe Anemia: a Prospective Cohort Study

Sixth Affiliated Hospital, Sun Yat-sen University2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年7月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
2
主要终点
remission rate of rectal bleeding after colostomy

研究概览

简要总结

Refractory rectal bleeding of chronic radiation proctitis (CRP) is still problematic and does not respond to medical treatments including reagents, endoscopic argon plasma coagulation (APC) or topical formalin. We proposed this prospective cohort study, to assess the efficacy and safety of colostomy in treating refractory hemorrhagic CRP with moderate to severe anemia, to provide higher-quality evidence of colostomy in these patients.

详细描述

Chronic radiation proctitis (CRP) is a common complication after radiotherapy of pelvic malignancies, accounting for 5%-20% of cases. Rectal bleeding is the most common symptom, which accounts for > 80% of CRP patients. Mild to moderate bleeding can be controlled by medical agents like sucralfate, endoscopic argon plasma coagulation (APC) or topical formalin. Severe and refractory bleeding is still problematic and refractory to these above medical treatments. Our previous retrospective study found that colostomy obtained a higher rate of bleeding remission (94% vs 12%) in 6 months, especially in control of transfusion-dependent bleeding (100% vs0%), when compared to conservative treatments.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically diagnosed with pelvic malignancies, including gynecologic, prostate, or urinary cancers;
  • History of pelvic radiation;
  • No tumor recurrence or metastasis;
  • Refractory hemorrhagic CRP;
  • Time of rectal bleeding >6 months;
  • SOBS=3 points;
  • severe anemia (Hb≤7 g/dl)or transfusion history for CRP bleedings.

排除标准

  • Severe complications of CRP, including deep ulcer or fistula, stricture, necrosis, refractory perianal pain;
  • Other hemorrhagic diseases, like III-IV degree hemorrhoids;
  • History of colon or rectum resection;
  • Intestinal obstruction and surgery needed;
  • with contraindications to general anaesthesia (ASA class 4 or 5);
  • pregnant or breast-feeding;
  • history of mental disorder.

结局指标

主要结局

remission rate of rectal bleeding after colostomy

时间窗: 6 mon after colostomy

retcal bleeding is assessed by soma scores

次要结局

  • Anorectal function outcomes(baseline, 6 months, 1 year, 2 years, 3 years)
  • endoscopic score(baseline, 6 months, 1 year, 2 years, 3 years)
  • Quality of life by EORTC scores(baseline, 6 months, 1 year, 2 years, 3 years)
  • Remission rate of rectal bleeding(1 year, 2years, 3 years)
  • Rate of colostomy closure(1 years, 1.5 years, 2 years)
  • Rate of severe CRP complications(3 years)
  • Rate of colostomy complications(baseline, 6 months, 1 year, 2 years, 3 years)

研究者

发起方
Sixth Affiliated Hospital, Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lei Wang

Professor

Sixth Affiliated Hospital, Sun Yat-sen University

研究点 (2)

Loading locations...

相似试验